Endovascular Management of Hepatic Encephalopathy

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) and spontaneous portosystemic shunts (SPSS) may lead to new or worsening hepatic encephalopathy (HE), especially in patients with chronic liver disease. Patients with medically refractory HE (rHE) may benefit from endovascular interventions. In this review, we briefly describe the post-TIPS and SPSS vascular anatomy, pathophysiology, classification, factors associated with HE, and the medical management of HE. In addition, we will discuss current endovascular techniques for HE management, their advantages, disadvantages, and review of the current literature.

Keywords

TIPS Reduction - hepatic encephalopathy - TIPS Occlusion - spontaneous portosystemic shunt

Publikationsverlauf

Artikel online veröffentlicht:
30. Juni 2021

• References

• 1 Mina Shaker WDC. Hepatic Encephalopathy. June 2014 August 2017 [cited 2019 09/16/2019]; Available from: http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hepatology/hepatic-encephalopathy/#summary. Accessed February 21, 2021
• 2 Madoff DC, Wallace MJ, Ahrar K, Saxon RR. TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics 2004; 24 (01) 21-36
• 3 Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y) 2011; 7 (04) 222-233
• 4 Ge PS, Runyon BA. Serum ammonia level for the evaluation of hepatic encephalopathy. JAMA 2014; 312 (06) 643-644
• 5 Wright G, Chattree A, Jalan R. Management of hepatic encephalopathy. Int J Hepatol 2011; 2011: 841407
• 6 Qi X, Ye C, Hou Y, Guo X. A large spontaneous intrahepatic portosystemic shunt in a cirrhotic patient. Intractable Rare Dis Res 2016; 5 (01) 58-60
• 7 Laleman W, Simon-Talero M, Maleux G. et al. EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 2013; 57 (06) 2448-2457
• 8 Córdoba J, Mínguez B. Hepatic encephalopathy. Semin Liver Dis 2008; 28 (01) 70-80
• 9 Shawcross DL, Olde Damink SW, Butterworth RF, Jalan R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab Brain Dis 2005; 20 (03) 169-179
• 10 Córdoba J. New assessment of hepatic encephalopathy. J Hepatol 2011; 54 (05) 1030-1040
• 11 Thornton, K. Evaluation and Prognosis of Patients with Cirrhosis. [Online Article] 2018 09/17/2019; 24].
• 12 Riggio O, Ridola L, Pasquale C. et al. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9 (07) 613-6.e1
• 13 Goldbecker A, Weissenborn K, Hamidi Shahrezaei G. et al. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut 2013; 62 (10) 1497-1504
• 14 Ong JP, Aggarwal A, Krieger D. et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114 (03) 188-193
• 15 D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (01) 217-231
• 16 Saad WE. Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy. Semin Intervent Radiol 2014; 31 (03) 262-265
• 17 Guillaume M, Bureau C. Should the presence of spontaneous portosystemic shunts be implemented to the model for end-stage liver disease score for a better prediction of outcome. ? Gastroenterology 2018; 154 (06) 1569-1571
• 18 Philips CA, Kumar L, Augustine P. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-a single-center experience in 21 patients from Kerala. Indian J Gastroenterol 2017; 36 (05) 411-419
• 19 Nguyen DL, Morgan T. Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view. Hepatol Int 2014; 8 (02/02) 447-451
• 20 Iris W. Liou, H.N.K. Diagnosis and Management of Hepatic Encephalopathy. [Electronic ] 2018 04/12/18 [cited 2019 09/17/2019]; Section 3, Topic 4:[
• 21 Khungar V, Poordad F. Hepatic encephalopathy. Clin Liver Dis 2012; 16 (02) 301-320
• 22 Pereira K, Carrion AF, Salsamendi J, Doshi M, Baker R, Kably I. Endovascular management of refractory hepatic encephalopathy complication of transjugular intrahepatic portosystemic shunt (tips): comprehensive review and clinical practice algorithm. Cardiovasc Intervent Radiol 2016; 39 (02) 170-182
• 23 Sanyal A, Younossi ZM, Bass NM. et al. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study. Aliment Pharmacol Ther 2011; 34 (08) 853-861
• 24 Yin X, Zhang F, Guo H. et al. A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients. Sci Rep 2020; 10 (01) 9381
• 25 Bai M, Qi X, Yang Z. et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 2011; 26 (06) 943-951
• 26 Casadaban LC, Parvinian A, Minocha J. et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes. Dig Dis Sci 2015; 60 (04) 1059-1066
• 27 Chung H-H, Razavi MK, Sze DY. et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?. J Gastroenterol Hepatol 2008; 23 (01) 95-101
• 28 Patil R, Rassameehiran S, Patel R, Balakrishnan M, Sood GK. Embolization for closure of spontaneous porto-systemic shunts in patient with cirrhosis and refractory hepatic encephalopathy: a systematic review and meta-analysis. Gastroenterology 2017; 152 (05) S1140
• 29 Pattynama PM, Wils A, van der Linden E, van Dijk LC. Embolization with the Amplatzer vascular plug in TIPS patients. Cardiovasc Intervent Radiol 2007; 30 (06) 1218-1221
• 30 Basseri S, Lightfoot CB. Balloon-occluded retrograde transvenous obliteration for treatment of bleeding gastric varices: case report and review of literature. Radiol Case Rep 2016; 11 (04) 365-369
• 31 Madoff DC, Wallace MJ. Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation. Semin Intervent Radiol 2005; 22 (04) 316-328
• 32 Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis 2012; 16 (01) 133-146
• 33 Cookson DT, Zaman Z, Gordon-Smith J, Ireland HM, Hayes PC. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series. Cardiovasc Intervent Radiol 2011; 34 (01) 92-99
• 34 Sze DY, Hwang GL, Kao JS. et al. Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment. J Vasc Interv Radiol 2008; 19 (11) 1653-1658
• 35 Hauenstein KH, Haag K, Ochs A, Langer M, Rössle M. The reducing stent: treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 1995; 194 (01) 175-179
• 36 Schultheiss M, Bettinger D, Boettler T, Thimme R, Rössle M. Severe hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS): value of shunt reduction and occlusion. JSM Hepat 2017; 2 (01) 1009
• 37 Pieper CC, Sprinkart AM, Nadal J. et al. Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents. J Vasc Interv Radiol 2015; 26 (03) 388-394
• 38 Miraglia R, Maruzzelli L, Di Piazza A. et al. Transjugular intrahepatic portosystemic shunt using the new Gore Viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience. Cardiovasc Intervent Radiol 2019; 42 (01) 78-86
• 39 Blue RC, Lo GC, Kim E. et al. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents using the “sheath control” technique. Cardiovasc Intervent Radiol 2016; 39 (06) 935-939
• 40 Jacquier A, Vidal V, Monnet O. et al. A modified procedure for transjugular intrahepatic portosystemic shunt flow reduction. J Vasc Interv Radiol 2006; 17 (08) 1359-1363
• 41 Kroma G, Lopera J, Cura M, Suri R, El-Merhi F, Reading J. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents. J Vasc Interv Radiol 2009; 20 (07) 981-986
• 42 Fanelli F, Salvatori FM, Rabuffi P. et al. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. AJR Am J Roentgenol 2009; 193 (06) 1696-1702
• 43 Angeloni S, Merli M, Salvatori FM. et al. Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol 2004; 99 (02) 280-285
• 44 Haskal ZJ, Middlebrook MR. Creation of a stenotic stent to reduce flow through a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1994; 5 (06) 827-829
• 45 Madoff DC, Perez-Young IV, Wallace MJ, Skolkin MD, Toombs BD. Management of TIPS-related refractory hepatic encephalopathy with reduced Wallgraft endoprostheses. J Vasc Interv Radiol 2003; 14 (03) 369-374
• 46 An J, Kim KW, Han S, Lee J, Lim YS. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther 2014; 39 (12) 1418-1426
• 47 Ibukuro K, Sugihara T, Tanaka R. et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. J Vasc Interv Radiol 2007; 18 (01) 121-125
• 48 Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. Am J Roentgenol 1996; 167 (05) 1317-1320
• 49 Chang M-Y, Kim MD, Kim T. et al. Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage. Korean J Radiol 2016; 17 (02) 230-238
• 50 Kim T, Yang H, Lee CK, Kim GB. Vascular plug assisted retrograde transvenous obliteration (PARTO) for gastric varix bleeding patients in the emergent clinical setting. Yonsei Med J 2016; 57 (04) 973-979
• 51 Kim DJ, Darcy MD, Mani NB. et al. Modified balloon-occluded retrograde transvenous obliteration (BRTO) techniques for the treatment of gastric varices: vascular plug-assisted retrograde transvenous obliteration (PARTO)/coil-assisted retrograde transvenous obliteration (CARTO)/balloon-occluded antegrade transvenous obliteration (BATO). Cardiovasc Intervent Radiol 2018; 41 (06) 835-847
• 52 Lee EW, Saab S, Gomes AS. et al. Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results. Clin Transl Gastroenterol 2014; 5 (10) e61-e61
• 53 Marsala A, Lee E. Coil-assisted retrograde transvenous obliteration: a valid treatment for gastric variceal hemorrhage and hepatic encephalopathy. Digestive Disease Interventions 2018; 01 (04) 302-305
• 54 Philips CA, Rajesh S, Augustine P, Padsalgi G, Ahamed R. Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options. Hepat Med 2019; 11: 23-34
• 55 Lynn AM, Singh S, Congly SE. et al. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy. Liver Transpl 2016; 22 (06) 723-731
• 56 Gaba RC. Retrograde-antegrade accelerated trap obliteration: a modified approach to transvenous eradication of gastric varices. J Vasc Interv Radiol 2017; 28 (02) 291-294
• 57 Naeshiro N, Kakizawa H, Aikata H. et al. Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: long-term outcomes in 14 patients. Hepatol Res 2014; 44 (07) 740-749
• 58 Lipnik AJ, Pandhi MB, Khabbaz RC, Gaba RC. Endovascular treatment for variceal hemorrhage: TIPS, BRTO, and combined approaches. Semin Intervent Radiol 2018; 35 (03) 169-184